South Africa's Health Regulator Allows Use of Merck Covid Treatment Pill

Reuters2022-02-17

JOHANNESBURG, Feb 17 (Reuters) - South Africa's health regulator SAHPRA said on Thursday that it had authorised use of Merck's COVID-19 treatment pill molnupiravir.

SAHPRA added in a statement that Pfizer had submitted an application for its COVID-19 pill, Paxlovid, which was under consideration.

"The authorisation of molnupiravir for compassionate use offers further therapy in the fight against COVID-19," SAHPRA's Chief Executive Boitumelo Semete-Makokotlela said.

SAHPRA said molnupiravir was only indicated for use in patients aged 18 years and older. It authorised with conditions the importation of a limited quantity of molnupiravir capsules for a period of six months.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

seetees
2022-02-18
seetees
Like
Shaine8862
2022-02-17
Shaine8862
[Cool]

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2212925619?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-02-17 20:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2212925619","market":"us","top_or_hot":-1,"title":"South Africa's Health Regulator Allows Use of Merck Covid Treatment Pill","media":"Reuters","content":"<html><head></head><body><p>JOHANNESBURG, Feb 17 (Reuters) - South Africa&#39;s health regulator SAHPRA said on Thursday that it had authorised use of Merck&#39;s    COVID-19 treatment pill molnupiravir.</p><p>SAHPRA added in a statement that Pfizer    had submitted an application for its COVID-19 pill, Paxlovid, which was under consideration.</p><p>&#34;The authorisation of molnupiravir for compassionate use offers further therapy in the fight against COVID-19,&#34; SAHPRA&#39;s Chief Executive Boitumelo Semete-Makokotlela said.</p><p>SAHPRA said molnupiravir was only indicated for use in patients aged 18 years and older. It authorised with conditions the importation of a limited quantity of molnupiravir capsules for a period of six months.</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>South Africa's Health Regulator Allows Use of Merck Covid Treatment Pill</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSouth Africa's Health Regulator Allows Use of Merck Covid Treatment Pill\n</h2>\n\n<h4 class=\"meta\">\n\n2022-02-17 20:47 北京时间&nbsp;&nbsp;&nbsp;<strong>Reuters</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>JOHANNESBURG, Feb 17 (Reuters) - South Africa's health regulator SAHPRA said on Thursday that it had authorised use of Merck's    COVID-19 treatment pill molnupiravir.SAHPRA added in a statement that ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4534","symbol_name":"瑞士信贷持仓","start_time":0,"source_url":"","article_id":"2212925619","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2212925619","pubTimestamp":1645102038,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"JOHANNESBURG, Feb 17 (Reuters) - South Africa's health regulator SAHPRA said on Thursday that it had","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4559":"巴菲特持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","BK4516":"特朗普概念","MRK":"默沙东","BK4007":"制药"},"translate_title":"南非卫生监管机构允许使用默克Covid治疗丸","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRK":1},"content_text":"JOHANNESBURG, Feb 17 (Reuters) - South Africa's health regulator SAHPRA said on Thursday that it had authorised use of Merck's    COVID-19 treatment pill molnupiravir.SAHPRA added in a statement that Pfizer    had submitted an application for its COVID-19 pill, Paxlovid, which was under consideration.\"The authorisation of molnupiravir for compassionate use offers further therapy in the fight against COVID-19,\" SAHPRA's Chief Executive Boitumelo Semete-Makokotlela said.SAHPRA said molnupiravir was only indicated for use in patients aged 18 years and older. It authorised with conditions the importation of a limited quantity of molnupiravir capsules for a period of six months.","kind":"highlight","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9094637673,"gmtCreate":1645138820423,"gmtModify":1676534000642,"author":{"id":"3562561688574892","authorId":"3562561688574892","name":"seetees","avatar":"https://static.tigerbbs.com/35829985f82fe3d891b427ca34c3e0b8","vip":1,"crmLevel":2,"crmLevelSwitch":1,"idStr":"3562561688574892","authorIdStr":"3562561688574892"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9094637673","repostId":2212925619,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9094892111,"gmtCreate":1645104801342,"gmtModify":1676533997333,"author":{"id":"3583799564024432","authorId":"3583799564024432","name":"Shaine8862","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3583799564024432","authorIdStr":"3583799564024432"},"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9094892111","repostId":2212925619,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":29,"commentSize":2,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2212925619"}